Advisory Board and Editors Immunology
Carlos M. de Noronha
Dr. Carlos de Noronha is Associate Professor within the Department of Immunology and Microbial Disease at Albany Medical College, USA.
His research focus is in the field of Microbiology, more specifically HIV, Molecular Virology, Viral Infection, Virus Diseases, Viral Immunology, Immunology of Infectious Diseases and Emerging Infectious Diseases.
Jane C. Deng
Assistant Professor of Medicine, Division of Pulmonary and Critical Care Medicine, UCLA School of Medicine.
Charles A. Dinarello
Charles A. Dinarello is Professor of Medicine and Immunology at the University of Colorado School of Medicine, and Professor of Experimental Medicine at Radboud University in the Netherlands.
Dr. Dinarello has published over 600 original research articles and 250 reviews and book chapters on cytokines, particularly on Interleukin-1, Interleukin-18, and related cytokines. The Institute for Scientific Information listed Dr. Dinarello as the world's 4th most-cited scientist during the 20 years from 1983-2002.
In 1998, Professor Dinarello was elected to the United States National Academy of Sciences, and in 2011, he became a foreign member of the Royal Netherlands Academy of Arts and Sciences. He is a member of the Board of Governors of the Weizmann Institute (Israel) and Ben Gurion University (Israel), former Vice President of the American Society of Clinical Investigation, and was President of the International Cytokine Society. He received the Squibb Award (USA), Ernst Jung Prize in Medicine (Germany), Chirone Prize (Italian National Academy of Medicine), Carol Nachman Prize (Germany), Sheikh Hamdan bin Rashdid al Madktoum Award (United Arab Emirates), Beering Prize (USA), Albany Prize in Medical Research (USA), Crafoord Prize of the Royal Swedish Academy of Sciences (Sweden), Paul Ehrlich Prize (Germany), Bonfils-Stanton Prize (USA), the Novartiz Prize in Clinical Immunology (Switzerland) and the Bonazinga Award (USA).
Barbara Ensoli
Director of the National AIDS Center, Istituto Superiore di Sanità, Rome, Italy. Co-Vice President and Member of the Presidential Committee of the AIDS National Commission, Ministry of Health. Member of the European Molecular Biology Organisation (EMBO).
Jorge MO Fernandes
Professor in Genomics and Molecular Biology. My main research interests are antimicrobial peptides, microRNAs and the epigenetic regulation of myogenic gene networks by environmental factors, such as temperature and photoperiod.
Alda Maria Ferreira
I have a master's degree in microbiology and PhD in Cellular and Molecular Biology. I am an Associate Professor of Immunology at the Federal University of Mato Grosso do Sul, Brazil. I have already supervised six master's and one doctoral students in the areas of biochemistry and infectious diseases.
My main area of interest is cellular and molecular biology of pathogens, infectious diseases and biological assays. So far I have published several papers involving studies in these areas.
I am the leader of a research group certified by the CNpQ (National Council for Scientific and Technological Development) on biological assays with >Trypanosoma cruzi<, which is the etiologic agent of Chagas disease.
Mario Alberto Flores-Valdez
Dr. Mario Alberto Flores-Valdez is a Professor in the Medical and Pharmaceutical Biotechnology Unit, CIATEJ, A.C., Guadalajara, Jalisco, Mexico (2007-present). He is a member of the National System of Researchers (SNI), and a member of the Mexican Academy of Sciences. He was a Stanford University Medical Center postdoctoral fellow (2004-2007), where he received a Dean's Fellowship Award (2006) to conduct research on Tuberculosis. He worked in UNAM as Research Assistant for Prof. Jaime Mora (2004) and Prof. Emundo Calva (2003). He has received a Ph.D. in Biochemistry from UNAM (1999-2003), a M.Sc. in Molecular Biology and Genetic Engineering from UANL (1996-1999) and a B.Sc. from Universidad de Sonora (1991-1996) in Chemistry and Biology. He received fellowships from CONACYT for M.Sc. and Ph.D. studies and in M.Sc. and B.Sc. has received Diplomas as Best Student. He has expertise in Tuberculosis, particularly in developing recombinant BCG strains. He has been PI for 7 grants from 2008 to date, focused in studies about tuberculosis vaccine development and basic aspects of mycobacterial physiology.
Lasse Folkersen
PhD in genetics from Karolinska Institute, Sweden. Research according to an overarching theme of my research is the use of high-throughput omics to bridge the gap between research and medicine. My initial interest was in expression quantitative trait loci (eQTL), and their possibilities for translating genetics to medical use. This followed a further step into actual industrial drug and pharmacogenetics development from the technique, performed at Novo Nordisk, Denmark. Current interests focus on further translation of main genetics results into actual use both in the clinical context of response stratification and in the industrial context of drug development.
Tamas Fulop
Dr. Tamàs Fülöp is Assistant Director of the Age Research Centre and Full Professor within the Faculty of Medicine and Health Sciences at the Université de Sherbrooke in Quebec, Canada. He is also Head of the Immune Inflammation Laboratory and Medical Director of the Memory Clinic.
M.D: From the Unversity of Geneva.
His postdoctoral research was in the biochemistry of connective tissues, and his PhD is in immunology and gerontology. His research interest is aging in relation to immunity.
Jeremiah J Gassensmith
Jeremiah's research focuses on several areas:
Development of stimuli responsive "smart" biomaterials
Creating new thermosalient molecular crystalline materials
Using metal-organic frameworks for native protein (i.e. drug) delivery
Supramolecular and macromolecular organic radical contrast agents as MRI sensors
Roi Gazit
Roi Gazit, PhD., is Principal Investigator of Hematopoietic Stem Cell (HSC) transcriptome laboratory at the Ben-Gurion University of the Negev, Israel. He is a member of the National Institute for Biotechnology in the Negev (NIBN), and the Center for Regenerative Medicine and Stem Cells at BGU. Roi earned a B.Sc. and M.Sc. in life science and developmental biology from the Hebrew University of Jerusalem. He obtained PhD. in immunology, under supervision of Ofer Mandelboim, studying NK-cell in vivo, including the generation of the first NK specific mouse model and elucidation of novel NK-cell abnormalities in human patients. He conducted postdoctoral studies at the Harvard Medical School, at Derrick J. Rossi laboratory, focusing on the identification and utilization of HSCs’ genes, including reprogramming of committed blood cells into HSCs using defined transcription-factors and generation of a novel HSC-reporter mouse. His laboratory at the Ben-Gurion University is studying HSCs’ transcriptome along normal development, during immune-challenges, and the direct reprogramming of adult blood cells into HSCs.
Delia Goletti
Delia Goletti MD, PhD, Infectious Diseases specialist. In 1992 she joined the Laboratory of Immunoregulation at the National Institutes of Health (chief Dr Fauci) working on HIV pathogenesis. In 1999 she joined the National Institute for Infectious Diseases in Rome. She has clinical duties on the tuberculosis (TB) clinic and responsibility of the Translational Research Unit where she works on TB pathogenesis, TB immunodiagnostic tests and impact of Heminths infection on HIV and TB disease.